Can a simple eye-tracking test spot autism in babies before their first birthday?

NCT ID NCT05916430

Recruiting now Diagnosis Sponsor: Emory University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a portable eye-tracking device can accurately screen 9-month-old infants for autism spectrum disorder (ASD). Over 2,000 babies will watch short videos while cameras track their eye movements. Researchers will then compare these results with standard autism diagnoses made at 24 months. If the device works well, it could lead to much earlier detection and support for children with autism.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: EarliPoint Investigational Device (eye-tracking test)
What this could lead to: If successful, this could enable routine, objective autism screening in infants as young as 9 months, allowing earlier support and intervention.
What could go wrong: The trial is still recruiting and results are not yet available. The eye-tracking test may not be accurate enough to replace current diagnostic methods, and early screening could cause unnecessary worry or false positives.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism Autism Spectrum Disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTISM INFANT DEVELOPMENT

Contacts and locations

Locations

Children's Healthcare of Atlanta
RECRUITING

Atlanta, Georgia, 30322, United States
Emory University
RECRUITING

Atlanta, Georgia, 30329, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.